Abbott India’s Managing Director Vivek V. Kamath Resigned
Abbott India Limited had informed the Stock Exchange about the resignation of Vivek V. Kamath as Managing Director with effect from March 18, 2024, to pursue other opportunities outside the company.
Vivek V. Kamath has over three decades of extensive and diverse experience in the healthcare sector, pharmaceuticals, over-the-counter (OTC) products, and diagnostics. Throughout his career, he has assumed key leadership roles in renowned pharmaceutical companies, both Indian and MNCs, across diverse geographical regions. Prior to his current position, he served as the General Manager of the Specialty Care division at Abbott Healthcare Private Limited. Before joining Abbott, he contributed to the success of organisations such as MSD Pharmaceuticals, Roche Diagnostics (India), Novartis (Singapore), Ranbaxy, Pfizer (India), Fulford (India), Wockhardt, and Johnson & Johnson. A science graduate with a specialisation in microbiology, he holds a master’s degree in management with a focus on marketing.